BioCryst Pharmaceuticals, Inc. 3Y Reveue Growth (CAGR)

3Y Reveue Growth (CAGR) of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Reveue Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Reveue Growth (CAGR) for 2021 was 96.7% (a -986.34% decrease from previous year)
  • Annual 3Y Reveue Growth (CAGR) for 2020 was -10.91% (a -147.79% decrease from previous year)
  • Annual 3Y Reveue Growth (CAGR) for 2019 was 22.83% (a -192.65% decrease from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Reveue Growth (CAGR) of BioCryst Pharmaceuticals, Inc.

Most recent 3Y Reveue Growth (CAGR)of BCRX including historical data for past 10 years.

Interactive Chart of 3Y Reveue Growth (CAGR) of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. 3Y Reveue Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 96.7%
2020 -10.91%
2019 22.83%
2018 -24.64%
2017 22.78%
2016 14.99%
2015 22.44%
2014 -11.52%
2013 -34.75%
2012 -18.32%

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology